• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD MEDICAL DIAGNOSTICS GMBH ANTI-HUMAN GLOBULIN ANTI-IGG,-C3D; POLYSPECIFIC (RABBIT/MURINE MONOCLONAL); IH-CARD AHG ANTI-IGG,-C3D (RABBIT / MURINE MONOCLONAL); 48 CARDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD MEDICAL DIAGNOSTICS GMBH ANTI-HUMAN GLOBULIN ANTI-IGG,-C3D; POLYSPECIFIC (RABBIT/MURINE MONOCLONAL); IH-CARD AHG ANTI-IGG,-C3D (RABBIT / MURINE MONOCLONAL); 48 CARDS Back to Search Results
Catalog Number 813411100
Medical Device Problem Code False Negative Result (1225)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/29/2022
Type of Reportable Event Malfunction
Event or Problem Description
Hold for em 6.30 the customer reported a false negative dat (direct anti-globulin test) result of an adult patient sample with an ih-card ahg anti-igg, -c3d.The customer tested on ih-1000 and manually.Additionally, the customer tested on the ih-card ahg anti-igg manually and on ih-1000 and received a positive result in each case.The customer provided the complaint sample ih-card ahg anti-igg, -c3d for investigational testing and also two patient samples.The customer returned two single cards.The investigation of our quality control laboratory is still ongoing.Also still ongoing is the investigation of the affected ih_1000 instrument.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective card lot.
 
Additional Manufacturer Narrative
This is our iniital report on this incident.
 
Event or Problem Description
The customer reported false negative dat (direct anti-globulin test) results of a cord blood sample and an adult sample.The customer tested on the ih-1000 instrument and manually and received discrepant results.The customer sent us 1 tube each of the two samples in question, as well as ih-cards from two different lots and configurations.The customer provided trace files of the affected ih-1000 instrument for investigation.The investigation did not give any indication for a malfunction of the affected dievice.Cord blood (id #476091) reacted negatively with ih-card ahg anti-igg lot #9126030 on the ih-1000 and in manual gel-card testing, but positively in tube testing with monospecific ahg.Repeat testing twice on the ih-1000 also resulted in negative reactions.A loading with anti-a of the cord blood was known.Adult blood (#477162) reacted negatively with the ih-card ahg anti-igg, -c3d lot #9111050 both on the ih1000, in the manual gel-card test and with the polyspecific ahg in the tube method.However, positive reactions occurred when using the ih-card ahg anti-igg lot #9126030, also in the repeat test on the ih-1000 and in the manual gel method.In the tube test with monospecific ahg, the sample reacted negatively.However, negative reactions occurred when using the ih-card ahg anti-igg lot #9133030 in the manual gel method.The ih-cards (lot #9126030 and lot #9111050) returned by the customer as well as our quality control lab's retention samples of the three ahg lots used by the customer were visually checked and did not show any abnormalities.All acceptance criteria were met.Since the two patient samples sent for investigational testing were in poor condition due to hemolysis, they first had to be washed several times for testing.The test was then performed on the ih-1000.Two known weakly igg loaded red blood cells were included as controls.Furthermore, six donor sample (dat negative) were tested.Result: both samples reacted negatively with both the customer cards and the three qc samples.The two known dat positive red blood cells reacted weakly positive; the six donor samples reacted negatively.The two provided patient samples were tested using the tube method with monospecific ahg, polyspecific ahg as well as polyspecific ahg from ortho.Both samples reacted negatively with all three ahgs used.The two patient samples were also tested in the manual gel method.The adult blood sample reacted negatively.The cord blood sample showed very weak positive reactions, which were only visible with the help of the illuminated box.Therefore, a 2% red blood cell suspension was prepared.This resulted in a 1+ reaction (the 2% red blood cell negative control was correctly negative).The two patient samples were checked in the id-card ahg anti-igg and id-card ahg anti-igg, -c3d.The adult blood sample reacted negatively.The cord blood sample showed a 1+ positive reaction in the id-card ahg.The cord blood sample was then tested in the dc screening card i with the result that the red blood cells were loaded with igg.The three ahg lots were checked for potency in comparison to the id-card ahg with anti-d and anti-fya loaded red blood cells.All cards showed comparable results.But the id-card reacted half a titer step stronger compared to the three ih-card lots.Based on the investigation the complaint was classified as unjustified.The negative reaction of the adult sample in the ih-card ahg anti-igg, -c3d was correct.The correct functioning of the three ih-cards in question could be verified.We could not confirm the positive reactions of the customer's adult sample in the ih-card ahg anti-igg lot #9126030.The sample reacted negatively in all tests.The root cause of the false positive reaction at customer´s site remained unknown.A carry over could be excluded.A review of the batch record documentation showed no irregularities which might have negatively affected the quality of the allegedly defective lot.
 
Additional Manufacturer Narrative
This is our final report on this incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ANTI-HUMAN GLOBULIN ANTI-IGG,-C3D; POLYSPECIFIC (RABBIT/MURINE MONOCLONAL)
Common Device Name
IH-CARD AHG ANTI-IGG,-C3D (RABBIT / MURINE MONOCLONAL); 48 CARDS
Manufacturer (Section D)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, hessen 63303
GM  63303
Manufacturer (Section G)
BIO-RAD MEDICAL DIAGNOSTICS GMBH
industriestrasse 1
dreieich, hessen 63303
GM   63303
Manufacturer Contact
martina benkert
industriestrasse 1
dreieich, hessen 63303
GM   63303
MDR Report Key14206334
Report Number9610824-2022-00017
Device Sequence Number1820689
Product Code QHS
UDI-Device Identifier07611969952151
UDI-Public(01)07611969952151(17)220719(10)9111050
Combination Product (Y/N)N
Initial Reporter StateCT
Initial Reporter CountryUS
PMA/510(K) Number
125529
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/19/2022
Device Catalogue Number813411100
Device Lot Number9111050
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/12/2022
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/30/2022
Supplement Date Received by Manufacturer03/30/2022
Initial Report FDA Received Date04/26/2022
Supplement Report FDA Received Date05/24/2022
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
IH-1000, SN (B)(4).; IH-1000, SN (B)(4).; IH-CARD AHG ANTI-IGG, LOT 9126030; IH-CARD AHG ANTI-IGG, LOT 9126030; IH-CARD AHG ANTI-IGG, LOT 9133030; IH-CARD AHG ANTI-IGG, LOT 9133030
Patient SexUnknown
-
-